Colgate-Palmolive CEO Noel Wallace recently sold more than 45,000 shares of NYSE:CL. The transaction involves the company’s ...

We recently published 10 Big Names Ending January With Explosive Gains. Colgate-Palmolive Company (NYSE:CL) was one of the ...

Although Colgate-Palmolive has lagged the broader market over the past year, analysts remain cautiously bullish on the ...

Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2025, with sales up 5.8% year on year to $5.23 billion. Its non ...

Colgate-Palmolive: Q4 earnings beat, strong cash flow, $5B buyback, and 5-year plan. Click here to read my most recent ...

Colgate Palmolive operates within the consumer staples sector, a space known across Canada for providing everyday household ...

Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite inconsistent Q4 ...

JP Morgan analyst Andrea Teixeira maintained an Overweight rating and raised the price target from $88 to $93 on Jan. 16, 2026. This analyst has an accuracy rate of 60%. UBS analyst Peter Grom ...

We recently compiled a list of the 10 Best Defensive Stocks According to Reddit. In this article, we will look at where Colgate-Palmolive Company (NYSE:CL) stands against the other defensive stocks.

Colgate-Palmolive Company (NYSE:CL) posted mixed results for the fourth quarter on Friday. The company reported a fourth-quarter sales decline of 0.12% year-on-year to $4.94 billion, missing the ...

Colgate-Palmolive and Introgen Therapeutics, Austin, Tex, biotechnology company, announce alliance to incorporate gene therapy into mouthwashes, gels and similar products to treat and prevent oral ...